Cargando…
Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC)
AIM: Six Phase III randomized trials have determined the effectiveness of chemoradiotherapy as primary treatment for anal squamous cell carcinoma (ASCC), but outcomes reported in these trials varied widely, hindering evidence synthesis. To improve reporting in all future trials, we aim to develop a...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5969105/ https://www.ncbi.nlm.nih.gov/pubmed/29566456 http://dx.doi.org/10.1111/codi.14103 |